Drugs For Schizophrenia
This is a two-part study designed to assess the effects of a new drug (AQW051) for schizophrenia. In the first part, scientists will assess brain function and memory in people with schizophrenia. The second part of the study will involve determining the effects of different doses of the study medication. This national study is currently recruiting patients.
Read moreMore information on "Drugs For Schizophrenia"
From Our Experts
Are Alzheimer’s and Schizophrenia Related?
Medicalnewstoday.com reports that, in a study by neuroscientists at Johns Hopkins, mice "lacking an enzyme that contributes to Alzheimer's... Read more »
Schizophrenia Drugs: The Latest Developments
This SharePost will be devoted to schizophrenia drugs in the pipeline. Bioline RX enrolled its first patient in their Phase II/III... Read more »
FDA Claims Pfizer Schizophrenia Drug Ad Misleading
The FDA has ruled that Pfizer violated the Federal Food, Drug and Cosmetic Act with a false or misleading advertisement in a medical... Read more »
Schizophrenia Drugs: The Older Atypicals
This SharePost is the second in a series devoted to schizophrenia treatment and it focuses specifically on some of the atypical drugs used... Read more »
Cross Titer News
It's ten o'clock and I write this from my dining table because I'm awake and wanted to talk about what happened when the medication I took... Read more »
From Our Sources
Clinical Trial: Study of a New Drug for Schizophrenia
This is a study to assess the safety and tolerability of multiple doses of a new drug called AQW051 in people with schizophrenia. This national... Read more »
Clinical trial: New drug for schizophrenia
This is a study to examine how well a new drug for schizophrenia--currently known as AQW051--helps enhance various kinds of brain function in people... Read more »
Clinical trial: New drug for schizophrenia
This is a study to compare the effects of a new drug, paliperidone palmitate, with Risperdal Consta in people who suffer from schizophrenia. This... Read more »
Osteoporosis Drug Shows Promise for Schizophrenia
A new study has found that the osteoporosis drug Evista (raloxifene) was effective at treating postmenopausal women with schizophrenia. Researchers... Read more »
Long-acting drug approved for schizophrenia
The U.S. Food and Drug Administration (FDA) has approved a sustained action form of the antipsychotic Invega for the treatment of schizophrenia.... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
